Research programme: tubulin polymerisation inhibitors - Abbott
Alternative Names: A 353476; A-318484; A-318492Latest Information Update: 24 Jan 2013
At a glance
- Originator Abbott Laboratories
- Class Hydrazones
- Mechanism of Action Tubulin polymerisation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Cancer